Genotyping diagnosis of acyclovir resistant herpes simplex virus;Détection par génotypage de la résistance des virus herpes simplex à l'aciclovir

Pathologie Biologie

Volumn 55, Issue 10, 2007, Pages 504-511

  Frobert, E ^a,b   Thouvenot, D ^a,b   Lina, B ^a,b   Morfin, F ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Acyclovir; DNA polymerase; Genotyping; Herpes simplex virus; Resistance; Thymidine kinase

Indexed keywords

ACICLOVIR; DNA POLYMERASE; FOSCARNET; NUCLEOTIDE; THYMIDINE KINASE; DNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; DIAGNOSTIC TEST; DNA POLYMERASE GENE; ENZYME POLYMORPHISM; GENE DELETION; GENE INSERTION SEQUENCE; GENE MUTATION; GENOTYPE; HERPES SIMPLEX VIRUS; IMMUNOCOMPROMISED PATIENT; PHOSPHORYLATION; PREVALENCE; THYMIDINE KINASE GENE; VIRUS CULTURE; VIRUS DETECTION; VIRUS REPLICATION; ANTIVIRAL RESISTANCE; DRUG EFFECT; ENZYMOLOGY; GENETICS; HERPES VIRUS INFECTION; HUMAN; INNATE IMMUNITY; MUTATION; POLYMERASE CHAIN REACTION; REVIEW;

ACYCLOVIR; AMINO ACID SUBSTITUTION; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; GENOTYPE; HERPESVIRIDAE INFECTIONS; HUMANS; IMMUNITY, NATURAL; MUTATION; POLYMERASE CHAIN REACTION; SIMPLEXVIRUS; THYMIDINE KINASE;

EID: 36649033113     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2007.08.005     Document Type: Article

References (78)

1. Tyring S.K., Baker D., and Snowden W. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir. J. Infect. Dis. 186 Suppl 1 (2002) S40-S46
2. Coen D.M., and Schaffer P.A. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA 77 (1980) 2265-2273
3. Field H.J., and Darby G. Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob. Agents Chemother. 17 (1980) 209-216
4. Burns W.H., Saral R., Santos G.W., Laskin O.L., Leitman P.S., McLaren C., et al. Isolation and characterization of resistant herpes simplex virus after acyclovir therapy. Lancet 1 (1982) 421-423
5. Nugier F., Collins P., Larder B.A., Langlois M., Aymard M., and Darby G. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J. Med. Virol. 36 (1992) 1-12
6. Christophers J., Clayton J., Craske J., Ward R., Collins P., Trowbridge M., et al. Survey of resistance of herpes simplex virus to acyclovir in Northwest England. Antimicrob. Agents Chemother. 42 (1998) 868-872
7. Danve-Scatanek C., Aymard M., Thouvenot D., Morfin F., Agius G., Bertin I., et al. A surveillance network of the herpes simplex virus resistance to antiviral drugs: a three year follow-up. J. Clin. Microbiol. 42 (2004) 242-249
8. Kost R.G., Hill E.L., Tigges M., and Staus S.E. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N. Engl. J. Med. 329 (1993) 1777-1782
9. Mouly F., Baccard M., Scieux C., Schneil L., Locq-Ebner S., Morinat F., et al. Chronic recurrent acyclovir-resitant genital herpes in an immunocompetent patient. Dermatology 190 (1995) 177
10. Swetter S.M., Hill E.L., Kerne E.R., Koelle D.M., Posavad C.M., Lawrence W., et al. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. J. Infect. Dis. 177 (1998) 543-550
11. Boon R.J., Bacon T.H., Robey H.L., Coleman T.J., Connolly A., Croson P., et al. Antiviral susceptibility of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based survey. J. Antimicrob. Chemother. 46 (2000) 324-325
12. Bacon T.H., Boon R.J., Schultz M., and Hodges-Savola C. Surveillance for antiviral agent resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob. Agents Chemother. 46 (2002) 3042-3044
13. Whitley R.J., and Gnann J.W. Acyclovir: a decade later. N. Engl. J. Med. 327 (1992) 782-789
14. Umar S.H., and Kanth A. Disseminated cutaneous herpes simplex virus type-1 with interstitial pneumonia as a first presentation of AIDS. J. Natl. Med. Asso. 91 (1999) 471-474
15. Momméja-Marin H., Lafaurie M., Scieux C., Galicier L., and Oksenhendler E. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. HIV/AIDS 37 (2003) 1527-1533
16. Sevilla J. Fatal hepatic failure secondary to acute herpes simplex infection. J. Pediatr. Hematol. Oncol. 26 (2004) 686-688
17. Englund J.A., Fletcher C.V., and Balfour H.H. Acyclovir therapy in neonates. J. Pediatr. 119 (1991) 129-135
18. Christophers J., Clayton J., Craske J., Ward R., Collins P., Trowbridge M., et al. Survey of resistance of herpes simplex virus to acyclovir in Northwest England. Antimicrob. Agents Chemother. 42 (1998) 868-872
19. Morfin F., Bilger K., Boucher A., Thiebaut A., Najioullah F., Bleyzac N., et al. HSV excretion after bone marrow transplantation: a 4-year survey. J. Clin. Virol. 30 (2004) 341-345
20. Stranska R., Schuurman R., Nienhuis E., Goedegebuure I.W., Polman M., Weel J.F., et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J. Clin. Virol. 32 (2005) 7-18
21. De Clercq E. Antiviral drugs: current state of the art. J. Clin. Virol. 22 (2001) 73-89
22. Safrin S., Crumpacker C., Chatis P., Davis R., Hafner R., Rush J., et al. A controlled trial comparing foscarnet therapy with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N. Engl. J. Med. 325 (1991) 551-555
23. Reusser P., Cordonnier C., Einsele H., Engelhard D., Link D., Locasciulli A., et al. European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Bone Marrox Transplantation 17 (1996) 813-817
24. Baumeister J., Fischer R., Eckenberg P., Henninger K., Ruebsamen-Waigmann H., and Kleymann G. Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease. Antivir Chem Chemo 18 (2007) 35-48
25. Betz U.A., Fischer R., Kleymann G., Hendrix M., and Rübsamen-Waigmann H. Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293. Antimicrob. Agents Chemother. 46 (2002) 1766-1772
26. Greco A., Calle A., Morfin F., Thouvenot D., Cayre M., Kindbeiter K., et al. S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target. FASEB J. 19 (2005) 1128-1130
27. Darby G., Larder B.A., and Inglis M.M. Evidence that the "active center" of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. J. Gen. Virol. 67 (1986) 753-758
28. Balasubramaniam N.K., Veerisetty V., and Gentry G.A. Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. J. Gen. Virol. 71 (1990) 2979-2987
29. Gaudreau A., Hill E., Balfour H.H., Erice A., and Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. J. Infect. Dis. 178 (1998) 297-303
30. Morfin F., Souillet G., Bilger K., Ooka T., Aymard M., and Thouvenot D. Genetic characterization of thymidine kinase from acyclovir-resistant and susceptible herpes simplex virus type 1 isolated from bone marrow transplant recipients. J. Infect. Dis. 182 (2000) 290-293
31. Bestman-Smith J., Schmit I., Papadopoulou B., and Boivin G. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J. Virol. 75 (2001) 3105-3110
32. Sasadeusz J.J., Tufaro F., Safrin S., Schubert K., Hubinette M.M., Cheung P.K., et al. Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir. J. Virol. 71 (1997) 3872-3878
33. Oram R.J., Marcellino D., Strauss D., Gustafson E., Talarico C.L., Root A.K., et al. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate. J. Infect. Dis. 181 (2000) 1458-1461
34. Saijo M., Suzutani T., Niikura M., Morikawa S., and Kurane I. Importance of the C-terminus of herpes simplex virus type 1 thymidine kinase for maintening thymidine kinase and acyclovir-phosphorylation activities. J. Med. Virol. 66 (2002) 388-393
35. Efstathiou S., Kemp S., Darby G., and Minson A.C. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70 (1989) 869-879
36. Coen D.M., Kosz-Vnenchak M., and Jacobson J.G. Thymidine kinase-negative herpes simplex virus mutant establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl. Acad. Sci. USA 86 (1989) 4736-4740
37. Sasadeusz J.J., and Sacks S.L. Spontaneous reactivation of thymidine kinase-deficient, acyclovir-resistant type 2 herpes simplex virus: masked heterogeneity or reversion?. J. Infect. Dis. 174 (1996) 476-482
38. Hwang C.B.C., Horsburgh B., Pelosi E., Roberts S., Digard P., and Coen D.M. A net + 1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant. Proc. Natl. Acad. Sc. USA 91 (1994) 5461-5465
39. Palu G., Gerna G., Bevilacqua F., and Marcello A. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res. 25 1-2 (1992) 133-144
40. Morfin F., Thouvenot D., Aymard M., and Souillet G. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene. J. Med. Virol. 62 (2000) 247-250
41. Gilbert C., Bestman-Smith J., and Boivin G. Resistance of herpes viruses to antiviral drugs: clinical impacts and molecular mechanisms. Drug Resist. Updat. 5 (2002) 88-114
42. Schmit I., and Boivin G. Characterization of the DNA polymerase and thymidine kinase genes of herpes simplex virus isolates from AIDS patients in whom acyclovir and foscarnet therapy sequentially failed. J. Infect. Dis. 180 (1999) 487-490
43. Pardeiro M., Cuenca-Estrella M., Fernandez-Clua M.A., Santos-O'Connor F., Tabares E., and Gadea I. Characterisation of penciclovir resistant acyclovir sensitive herpes simplex virus type 2 isolated from an AIDS patient. J. Med. Virol. 73 (2004) 60-64
44. Evans J.S., Lock K.P., Levine B.A., Champness J.N., Sanderson M.R., Summers W.C., et al. Herpes thymidine kinases: laxity and resistance by design. J. Gen. Virol. 79 (1998) 2092-2093
45. Hwang C.B., and Chen H.J. An altered spectrum of herpes simplex virus mutations mediated by an antimutator DNA polymerase. Gene 152 (1995) 191-193
46. Retchin T.M., Black M.E., Mao F., Lewis M.L., and Drake R.R. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase. J. Biol. Chem. 270 (1995) 7055-7060
47. Michael M., Fetzer J., and Folkers G. Site-directed mutagenesis of herpes simplex virus type 1 thymidine kinase opposes the importance of amino acid positions 251, 321, and 348 for selective recognition of substrate analogs. Biochem. Biophys. Res. Com. 209 (1995) 966-973
48. Chiba A., Suzutani T., Saijo M., Koyano S., and Azuma M. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus. Acta Virol. 42 (1998) 401-407
49. Kudo E., Shiota H., Naito T., Satake K., and Itakura M. Polymorphisms of thymidine kinase gene in herpes simplex virus type 1: analysis of clinical isolates from herpetic keratitis patients and laboratory strains. J. Med. Virol. 56 (1998) 151-158
50. Chibo D., Druce J., Sasadeusz J., and Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res. 61 (2004) 83-91
51. Andrei G., Snoeck R., De Clercq E., Esnouf R., Fiten P., and Opdenakker G. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivates of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene. J. Gen. Virol. 81 (2000) 639-648
52. Chibo D., Mijch A., Doherty R., and Birch C. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir viruses infecting an immunocompromised patient. J. Clin. Virol. 25 (2002) 165-170
53. Sacks S.L., Wanklin R.J., Reece D.E., Hicks K.A., Tyler K.L., and Coen D.M. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?. Ann. Intern. Med. 111 (1989) 893-899
54. Stranska R., Van Loon A.M., Bredius R.G., Polman M., Nienhuis E., Beersma M.F., et al. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child. Antivir. Ther. 9 (2004) 97-104
55. Larder B.A., and Darby G. Virus drug-resistance: mechanisms and consequences. Antiviral Res. 4 (1984) 1-42
56. Larder B.A., and Darby G. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology 146 (1985) 262-271
57. Marcy A.I., Hwang C.B., and Coen D.M. Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrat recognition. J. Virol. 64 (1990) 5883-5890
58. Gibbs J.S., Chiou H.C., Bastow K.F., Cheng Y.C., and Coen D.M. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc. Natl. Acad. Sci. USA 85 (1988) 6672-6676
59. Saijo M., Suzutani T., Morikawa S., and Kurane I. Genotypic characterization of the DNA polymerase and sensitivity to antiviral compounds of foscarnet-resistant herpes simplex virus type 1 (HSV-1) derived from a foscarnet-sensitive HSV-1 strain. Antimicrob. Agents Chemother. 49 (2005) 606-611
60. Hwang Y.T., Liu B.Y., Coen D.M., and Hwang C.B.C. Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity. J. Virol. 71 (1997) 7791-7798
61. Visse B., Huraux J.M., and Fillet A.M. Point mutation in the varicella-zoster virus DNA polymerase gene confers resistance to foscarnet and slow growth phenotype. J. Med. Virol. 59 (1999) 84-90
62. Wyles D.L., Patel A., Madinger N., Bessesen M., Krause P.R., and Weinberg A. Development of herpes simplex virus disease in patients who are receiving cidofovir. Clin. Infect. Dis. 41 (2005) 676-680
63. Swierkosz E.M., Scholl D.R., Brown J.L., Jollick J.D., and Gleaves C.A. Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31 (1987) 1465-1469
64. Pavic I., Hatmann A., Zimmermann A., Michel D., Hampl W., Schleyer I., et al. Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. Antimicrob. Agents Chemother. 41 (1997) 2686-2692
65. Safrin S., Palacios E., and Leahy B.J. Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates. Antimicrob. Agents Chemother. 40 (1996) 1017-1019
66. Langlois M., Allard J.P., Nugier F., and Aymard M. A rapid and automated colorimetric assay for evaluating the sensitivity of herpes simplex strains to antiviral drugs. J. Biol. Stand. 14 (1986) 201-211
67. Stranska R., Van Loon A.M., Polman M., and Schuurman R. Application of real-time PCR for antiviral drug susceptibility determination of herpes simplex virus. Antimicrob. Agents Chemother. 46 (2002) 2943-2947
68. Thi T.N., Deback C., Malet I., Bonnafous P., Ait-Arkoub Z., and Agut H. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR. Antiviral Res. 69 (2006) 152-157
69. Boivin G. Drug-resistant herpesviruses: should we look for them?. Eur. J. Clin. Microbiol. Infect. Dis. 17 (1998) 539-541
70. Frobert E., Ooka T., Cortay J.C., Lina B., Thouvenot D., and Morfin F. Herpes simplex thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob. Agents Chemother. 49 (2005) 1055-1059
71. Frobert E., Ooka T., Cortay J.C., Lina B., Thouvenot D., and Morfin F. Resistance of herpes simplex virus type 1 to acyclovir: thymidine kinase gene mutagenesis study. Antiviral Res. 73 (2007) 147-150
72. Ducancelle A., Alain S., Scieux C., Fillet A.M., Petit F., Sanson-Le Pors M.J., et al. A novel colorimetric test to study the susceptibility of human cytomegalovirus DNA polymerase to foscarnet. Pathol. Biol. 53 (2005) 551-555
73. Ducancelle A., Alain S., Petit F., Sanson Le Pors M.J., and Mazeron M.C. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet. J. Virol. Methods 141 (2007) 212-215
74. Wen H., and Li Q. Real-time PCR detection of multiple lamivudine-resistant mutations with displacing probes in a single tube. J. Clin. Virol. 38 (2007) 334-340
75. Esaki H., Noda K., Otsuki N., Kojima A., Asai T., Tamura Y., et al. Rapid detection of quinolone-resistant Salmonella by real-time SNP genotyping. J Microb Methods 58 (2004) 131-134
76. Yeo A.C., Chan K.P., Kumarasinghe G., and Yap H.K. Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons. Mol. Cell. Probes 19 (2005) 389-393
77. Vahey M., Nau M.E., Barrick S., Cooley J.D., Sawyer R., Sleeker A.A., et al. Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates ith length polymorphims. J. Clin. Microbiol. 37 (1999) 2533-2537
78. Troesch A., Nguyen H., Miyada C.G., Desvarenne S., Gingeras T.R., Kaplan P.M., et al. Mycobacterium species identification and rifampicin resistance testing with high-density DNA probe arrays. J. Clin. Microbiol. 37 (1999) 49-55